HighTower Advisors’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
Other funds holding TMDX
NAMI
HRCM
B
HighTower Advisors's TMDX Position: Q2 2026 in Review
HighTower Advisors reduced its Transmedics (TMDX) stake by 60% in Q2 2026, selling an estimated $631K and leaving 5,068 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #3112.
HighTower Advisors first reported a position in TMDX in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.63M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.
- HighTower Advisors held 5,068 shares of Transmedics worth $337K as of Q2 2026.
- HighTower Advisors sold 7,451 Transmedics shares in Q2 2026, an estimated $631K.
- Transmedics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3112 holding.
- HighTower Advisors first reported a position in Transmedics in Q1 2021 and has held it in 21 quarters since.
- HighTower Advisors's Transmedics position peaked at $3.63M in Q3 2024.
- 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.